YRMC Marketing Coordinator
(November 19, 2013 – Yuma, AZ) As part of its commitment to provide the latest treatment options to its patients, Yuma Regional Medical Center (YRMC) has launched a clinical trial program that will enable patients to participate in cutting-edge research studies without having to travel to another city. The first clinical trials to be offered will be in the fields of cardiology, oncology and diabetes.
Clinical trials are designed to test the effectiveness of new treatments and medical devices. They are the final step in a long process that begins with laboratory research. Many medical treatments used today are the result of past clinical trials. Patients who participate in these trials do so voluntarily to fulfill their desire to seek the most advanced treatment options possible.
YRMC's first cardiology clinical trial will begin this week when cardiologist Dr. Joseph Cardenas performs a balloon angioplasty procedure on a patient in an attempt to relieve leg pain caused by a narrowing of the blood vessels in the patient's leg. The medical device Dr. Cardenas will use is identical to regular angioplasty balloons, but it is coated with a special medication. YRMC is the only medical facility in Arizona that was selected to participate in this clinical trial.
YRMC has launched clinical trials in the field of oncology as part of its national accreditation as a cancer center. YRMC has a collaborative partnership with Mayo Clinic and will be conducting some of the same clinical trials as the Mayo Clinic. The first two clinical trials offered by YRMC in the field of oncology are (1) an advanced breast cancer trial using genetic information to determine treatment and (2) a supportive care trial designed to test the effectiveness of a new treatment for depression in cancer patients.
Clinical trials in the study of diabetes are now ongoing at YRMC. Preventing type 1 diabetes begins by identifying people who are at risk to develop the disease. Yuma Regional Medical Center now has the ability to offer free risk screenings for relatives of people with type 1 diabetes.
“These are the first trials of many more to come,” states Pat Walz, President and CEO of Yuma Regional Medical Center. “This is an exciting time for YRMC. Our new clinical trial program will enable Yuma area residents to pursue additional treatment options that are on the cutting edge of medical research without having to travel outside of the area.”